Cargando…

Type I neurofibromatosis with spindle cell sarcoma: A case report

BACKGROUND: Neurofibromatosis type I (NF1) is the most frequent subtype of neurofibromatosis. Its related tumor-suppressor syndromes are characterized by a predisposition to multiple tumor types and other disorder presentations. In addition, the incidence of tumors is much higher in patients with ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yu, Chao, Jiao-Jiao, Liu, Xiu-Feng, Qin, Shu-Kui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795717/
https://www.ncbi.nlm.nih.gov/pubmed/31624761
http://dx.doi.org/10.12998/wjcc.v7.i19.3104
_version_ 1783459499229577216
author Zhang, Yu
Chao, Jiao-Jiao
Liu, Xiu-Feng
Qin, Shu-Kui
author_facet Zhang, Yu
Chao, Jiao-Jiao
Liu, Xiu-Feng
Qin, Shu-Kui
author_sort Zhang, Yu
collection PubMed
description BACKGROUND: Neurofibromatosis type I (NF1) is the most frequent subtype of neurofibromatosis. Its related tumor-suppressor syndromes are characterized by a predisposition to multiple tumor types and other disorder presentations. In addition, the incidence of tumors is much higher in patients with neurofibromatosis type I. However, there are very few reports at home and abroad on this topic. Here, we present a case of NF1 with spindle cell sarcoma. CASE SUMMARY: A 50-year-old male was found to have a right axillary mass for 20 years. Specialist examination found cafe-au-lait spots on many parts of the skin, rounded nodules in the skin, a bulge in the right armpit, touching a lump (10 cm × 6 cm, hard, unclear boundary, poor mobility, local tenderness). The anterior side of the thigh felt weakened on the opposite side; in the right groin a swollen lymph node (hard, clear border, good mobility, local tenderness). According to the results of positron emission tomography/computed tomography, puncture pathology and immunohistochemistry, genetic testing, a diagnosis of NF1 with spindle cell sarcoma was confirmed. According to the genetic testing result, the patient was given a targeted treatment with crizotinib. CONCLUSION: Surgery, chemotherapy and radiotherapy are the main treatment methods of NF1. However, with the continuous progress of molecular biology research, molecular targeted therapy may bring benefits for patients.
format Online
Article
Text
id pubmed-6795717
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-67957172019-10-17 Type I neurofibromatosis with spindle cell sarcoma: A case report Zhang, Yu Chao, Jiao-Jiao Liu, Xiu-Feng Qin, Shu-Kui World J Clin Cases Case Report BACKGROUND: Neurofibromatosis type I (NF1) is the most frequent subtype of neurofibromatosis. Its related tumor-suppressor syndromes are characterized by a predisposition to multiple tumor types and other disorder presentations. In addition, the incidence of tumors is much higher in patients with neurofibromatosis type I. However, there are very few reports at home and abroad on this topic. Here, we present a case of NF1 with spindle cell sarcoma. CASE SUMMARY: A 50-year-old male was found to have a right axillary mass for 20 years. Specialist examination found cafe-au-lait spots on many parts of the skin, rounded nodules in the skin, a bulge in the right armpit, touching a lump (10 cm × 6 cm, hard, unclear boundary, poor mobility, local tenderness). The anterior side of the thigh felt weakened on the opposite side; in the right groin a swollen lymph node (hard, clear border, good mobility, local tenderness). According to the results of positron emission tomography/computed tomography, puncture pathology and immunohistochemistry, genetic testing, a diagnosis of NF1 with spindle cell sarcoma was confirmed. According to the genetic testing result, the patient was given a targeted treatment with crizotinib. CONCLUSION: Surgery, chemotherapy and radiotherapy are the main treatment methods of NF1. However, with the continuous progress of molecular biology research, molecular targeted therapy may bring benefits for patients. Baishideng Publishing Group Inc 2019-10-06 2019-10-06 /pmc/articles/PMC6795717/ /pubmed/31624761 http://dx.doi.org/10.12998/wjcc.v7.i19.3104 Text en ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Case Report
Zhang, Yu
Chao, Jiao-Jiao
Liu, Xiu-Feng
Qin, Shu-Kui
Type I neurofibromatosis with spindle cell sarcoma: A case report
title Type I neurofibromatosis with spindle cell sarcoma: A case report
title_full Type I neurofibromatosis with spindle cell sarcoma: A case report
title_fullStr Type I neurofibromatosis with spindle cell sarcoma: A case report
title_full_unstemmed Type I neurofibromatosis with spindle cell sarcoma: A case report
title_short Type I neurofibromatosis with spindle cell sarcoma: A case report
title_sort type i neurofibromatosis with spindle cell sarcoma: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795717/
https://www.ncbi.nlm.nih.gov/pubmed/31624761
http://dx.doi.org/10.12998/wjcc.v7.i19.3104
work_keys_str_mv AT zhangyu typeineurofibromatosiswithspindlecellsarcomaacasereport
AT chaojiaojiao typeineurofibromatosiswithspindlecellsarcomaacasereport
AT liuxiufeng typeineurofibromatosiswithspindlecellsarcomaacasereport
AT qinshukui typeineurofibromatosiswithspindlecellsarcomaacasereport